Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 134.20
Bid: 135.00
Ask: 135.60
Change: -0.80 (-0.59%)
Spread: 0.60 (0.444%)
Open: 135.00
High: 136.00
Low: 133.20
Prev. Close: 135.00
KIE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

30 Mar 2020 07:01

RNS Number : 9565H
Kier Group PLC
30 March 2020
 

Kier Group plc

Board Changes

Kier Group plc (the "Company" or the "Group") announces the appointments of Mr. Clive Watson and Dame Heather Rabbatts to its board of directors (the "Board") with immediate effect.

Clive Watson is currently a non-executive director of Breedon Group plc and discoverIE Group plc, where he is the Chair of the Audit and Risk Committee, having previously been a non-executive director of Spirax-Sarco Engineering plc, where he was the Senior Independent Director and the Chair of the Audit Committee. During his executive career, Clive was the Group Finance Director at Spectris plc from 2006-2019, having previously held a number of senior finance positions at Borealis, Thorn Lighting Group and The Black & Decker Corporation.

Clive will be the Chair of the Risk Management and Audit Committee and a member of the Nomination Committee, the Remuneration Committee and the Safety, Health and Environment Committee.

Justin Atkinson will stand down from the role of acting Chair of the Risk Management and Audit Committee with immediate effect and continue in the role of Senior Independent Director.

Heather Rabbatts has held a number of executive and non-executive positions in the local government, entertainment and sport sectors, in particular. Heather is currently the Chair of Soho Theatre Company and her recent non-executive directorships include Crossrail, the Football Association, where she was a member of the Remuneration Committee, and Grosvenor Britain & Ireland, where she was the Chair of the Audit Committee.

Heather will be the Chair of the Remuneration Committee and a member of the Nomination Committee, the Risk Management and Audit Committee and the Safety, Health and Environment Committee.

Constance Baroudel, the current Chair of the Remuneration Committee, will stand down from the Board with immediate effect.

Matthew Lester, Chairman, said: "We are delighted that Clive and Heather will be joining the Board. Both have a depth of experience which will be invaluable as the Board continues to oversee the delivery of the Group's strategic objectives. I look forward to working with Clive and Heather.

I would like to thank Constance for her contribution over almost four years on the Board. I would also like to thank Justin for undertaking the role of Chair of the Risk Management and Audit Committee on an interim basis.

As the Chair of the Remuneration Committee, Heather will be engaging with shareholders with respect to the Company's revised remuneration policy, which will assist her to understand the reasons for the significant vote against the Directors' Remuneration Report at the 2019 AGM and to consider any actions which may need to be taken as a result."

In relation to the appointment of Clive Watson, no further information is required to be disclosed pursuant to Listing Rule 9.6.13R.

In relation to the appointment of Heather Rabbatts, no information is required to be disclosed pursuant to Listing Rule 9.6.13R.

 

Further information

Please contact:

 

Kier Press Office 

+44 (0)1767 355 096

Richard Mountain/Nick Hasell - FTI Consulting 

+44 (0)20 3727 1340

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2019 and the Company's results announcement for the six months ended 31 December 2019 for further information about the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAMZGZFRLKGGZM
Date   Source Headline
7th Oct 202211:51 amRNSAnnual Financial Report
3rd Oct 202210:23 amRNSTotal Voting Rights
21st Sep 20223:42 pmRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSResults for the year ended 30 June 2022
2nd Sep 202210:08 amRNSHolding(s) in Company
1st Sep 202210:21 amRNSTotal Voting Rights
22nd Aug 202210:11 amRNSDirector/PDMR Shareholding
1st Aug 202210:00 amRNSTotal Voting Rights
29th Jul 20224:05 pmRNSHolding(s) in Company
20th Jul 202212:00 pmRNSDirector/PDMR Shareholding
19th Jul 20227:00 amRNSTrading Update
6th Jul 20227:00 amRNSBoard Appointment
1st Jul 202210:16 amRNSTotal Voting Rights
1st Jul 202210:14 amRNSBlock listing Interim Review
28th Jun 20229:41 amRNSHolding(s) in Company
22nd Jun 20224:29 pmRNSHolding(s) in Company
21st Jun 202211:44 amRNSDirector/PDMR Shareholding
1st Jun 202210:36 amRNSTotal Voting Rights
24th May 20227:00 amRNSTrading Update and Capital Markets Event
20th May 20222:36 pmRNSDirector/PDMR Shareholding
3rd May 202210:30 amRNSTotal Voting Rights
29th Apr 20221:00 pmRNSDirector Declaration
19th Apr 20224:32 pmRNSDirector/PDMR Shareholding
1st Apr 202212:28 pmRNSTotal Voting Rights
21st Mar 20222:05 pmRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSResults for the six months ended 31 December 2021
1st Mar 202212:07 pmRNSTotal Voting Rights
21st Feb 20223:08 pmRNSDirector/PDMR Shareholding
2nd Feb 20223:05 pmRNSHolding(s) in Company
1st Feb 202212:07 pmRNSTotal Voting Rights
20th Jan 202212:18 pmRNSDirector/PDMR Shareholding
20th Jan 20227:00 amRNSTrading Update
4th Jan 202212:05 pmRNSTotal Voting Rights
4th Jan 202212:00 pmRNSBlock listing Interim Review
20th Dec 20214:10 pmRNSDirector/PDMR Shareholding
1st Dec 20212:37 pmRNSTotal Voting Rights
22nd Nov 20213:14 pmRNSDirector/PDMR Shareholding
19th Nov 20212:32 pmRNSResult of AGM
15th Nov 20211:13 pmRNSHolding(s) in Company
1st Nov 20213:17 pmRNSDirector/PDMR Shareholding
1st Nov 20219:38 amRNSTotal Voting Rights
29th Oct 202112:59 pmRNSDirector/PDMR Shareholding
26th Oct 20211:00 pmRNSDirector/PDMR Shareholding
19th Oct 20213:47 pmRNSDirector/PDMR Shareholding
19th Oct 202110:00 amRNSHolding(s) in Company
15th Oct 202111:43 amRNSAnnual Financial Report
5th Oct 202111:04 amRNSDirector/PDMR Shareholding
30th Sep 20219:33 amRNSHolding(s) in Company
21st Sep 20212:17 pmRNSDirector/PDMR Shareholding
20th Sep 20214:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.